Trial Site Detail

 

Drug:
NN3201
Trial:
A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/​or Metastatic Solid Tumors Known to Express C-Kit
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Oregon Health & Science University

     
Portland , OR 97239
USA

 

Principal Investigator:
 Michael Heinrich, MD
Contact:
 Michael Heinrich, MD 503-220-3405 heinrich@ohsu.edu
Activation Status of this Site:
 Active
Notes about this Site:
Oregon Health & Science University Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.